JOHN FARMER to Cholesterol, LDL
This is a "connection" page, showing publications JOHN FARMER has written about Cholesterol, LDL.
Connection Strength
0.781
-
Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol. Nat Clin Pract Cardiovasc Med. 2006 Dec; 3(12):664-72.
Score: 0.203
-
Reversal of atherosclerosis with aggressive lipid lowering. Curr Atheroscler Rep. 2005 Mar; 7(2):86-7.
Score: 0.180
-
Aggressive lipid therapy in the statin era. Prog Cardiovasc Dis. 1998 Sep-Oct; 41(2):71-94.
Score: 0.115
-
Intensive versus moderate lipid lowering with statins in acute coronary syndromes. Curr Atheroscler Rep. 2005 Mar; 7(2):85-6.
Score: 0.045
-
Rationale for aggressive lipid lowering: evidence from clinical trials. Expert Rev Cardiovasc Ther. 2004 May; 2(3):305-9.
Score: 0.042
-
Benefits of simvastin in cholesterol lowering. Curr Atheroscler Rep. 2003 Mar; 5(2):93-4.
Score: 0.039
-
Benefits of atorvastatin in cholesterol lowering. Curr Atheroscler Rep. 2003 Mar; 5(2):94-5.
Score: 0.039
-
Atherosclerosis and inflammation. Curr Atheroscler Rep. 2002 Mar; 4(2):92-8.
Score: 0.037
-
Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]). Am J Cardiol. 1997 Aug 01; 80(3):278-86.
Score: 0.027
-
Choosing the right lipid-regulating agent. A guide to selection. Drugs. 1996 Nov; 52(5):649-61.
Score: 0.025
-
Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy. Circulation. 1999 Feb 16; 99(6):736-43.
Score: 0.007
-
Effects of lipid lowering therapy on progression of coronary and carotid artery disease. Curr Opin Lipidol. 1997 Dec; 8(6):354-61.
Score: 0.007
-
Effect of gemfibrozil on levels of lipoprotein[a] in type II hyperlipoproteinemic subjects. J Lipid Res. 1996 Jun; 37(6):1298-308.
Score: 0.006
-
Baseline characteristics of subjects in the Lipoprotein and Coronary Atherosclerosis Study (LCAS) with fluvastatin. Am J Cardiol. 1994 May 26; 73(14):42D-49D.
Score: 0.005
-
Once-daily pravastatin in patients with primary hypercholesterolemia: a dose-response study. Clin Cardiol. 1991 Feb; 14(2):146-51.
Score: 0.004